Drug Shortage Report for MINT-IRBESARTAN
Report ID | 80803 |
Drug Identification Number | 02423006 |
Brand name | MINT-IRBESARTAN |
Common or Proper name | Irbesartan |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-04-08 |
Estimated end date | 2020-06-30 |
Actual end date | 2021-06-22 |
Shortage status | Resolved |
Updated date | 2021-07-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-07-12 | French | Compare |
v10 | 2021-07-12 | English | Compare |
v9 | 2020-01-27 | French | Compare |
v8 | 2020-01-27 | English | Compare |
v7 | 2019-07-04 | French | Compare |
v6 | 2019-07-04 | English | Compare |
v5 | 2019-06-15 | French | Compare |
v4 | 2019-06-15 | English | Compare |
v3 | 2019-04-09 | English | Compare |
v2 | 2019-04-08 | French | Compare |
v1 | 2019-04-08 | English | Compare |
Showing 1 to 11 of 11